Pappas Capital
Venture capitalResearch Triangle Park · Seed–Late Stage · 15 people tracked
Also known as A.M. Pappas & Associates, LLC · PAPPAS CAPITAL, LLC
Find your way into Pappas Capital
2,069 people in our graph share verified history with the Pappas Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Pappas Capital focuses on the life sciences, investing in and building innovative companies that develop next-generation life science products and technologies. Over more than three decades it has backed over 100 companies across the United States, Canada, and Asia, spanning the full range of human disease. Its portfolio companies have brought to market products treating conditions such as melanoma, ovarian cancer, and hemophilia, which have been used worldwide to treat tens of thousands of patients and generated billions of dollars in revenue. The firm offers both capital and operational expertise to founders building life science businesses.
Source: firm website, verified Aug 3, 2026.
Team · 15 people
from curated & public directoriesWhat they invest in
from 12 of 12 portfolio companiesBiotech ×7Healthtech ×7Medical Devices ×3Climate Tech ×2AI & Machine Learning ×1Cleantech ×1Cloud Computing ×1Consumer ×1
HQs:United States×5Germany×1Singapore×1Vietnam×1
Investments · 12 tracked
founders shown can be your intro pathBy year:2025 · 12022 · 22021 · 12020 · 22017 · 17 dated
Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors.
BiotechHealthtechMedical DevicesBoston, US
Todd Foley(Co-founder and Chairman)inPatrick Baeuerle(Co-founder & Advisor)inShulamit Ron-Bigger(Executive Officer)inKyle D. Kuvalanka(Chief Financial Officer)inAkos Czibere(Chief Medical Officer)inPaul L. Feldman(Chief Scientific Officer)in
Co-investorsAndreessen HorowitzEcoR1 CapitalMPM BioImpactMRL Ventures FundRA CapitalTCG Crossover+4 more
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtech
Anthony Fordin
Co-investorsAlta PartnersLongitude Capitalabrdn plcIntermediate Capital GroupJohnson & Johnson Innovation – JJDCNew Leaf Venture Partners+2 more
Sorriso Pharma is a biopharmaceutical company backed by leading venture capital firms specializing in life sciences and healthcare investments.
BiotechHealthtechMedical DevicesSandy, US
Ciara Kennedy, Ph.D.(Executive Officer, Director)Brian Dorsey(Executive Officer)Michael Grey(Director)Mark Chin(Director)Susan Dube(Executive Officer)
BoardEdward Mathers(Director)
Co-investorsNew Enterprise Associates (NEA)NEA Secondary
Reneo is an asset and investment management platform for decarbonizing residential real estate portfolios in Germany.
Climate TechEnterprise SoftwarePropTechGermany, DE
Lennart Börner(Founder & Co-CEO)inAlexander Graubner-Müller(Founder & Co-CEO)in
Co-investorsFoundamentalAbingworthAisling CapitalAmzak HealthEurazeoLakestar+4 more
Xoilac TV is a free online football (soccer) live-streaming platform serving fans in Vietnam, offering Full HD match broadcasts of European, Asian, Vietnamese, and international competitions.
ConsumerMedia & EntertainmentSports Tech
Co-investorsAisling CapitalNew Enterprise Associates (NEA)AbingworthAmzak HealthLundbeckfonden VenturesRiverVest Venture Partners+1 more
BiotechGreenville, US
Kevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)
Co-investorsHatteras Venture PartnersIllumina VenturesM VenturesMC Healthcare VenturesPappas CapitalSV Health Investors+1 more
HealthtechPlymouth, US
Thomas Westling(Executive Officer, Director)inMartha Shadan(Executive Officer, Director)Randy Nuernberg(Executive Officer)Craig Van Kampen(Executive Officer)
BoardFouad Azzam(Director)inScott Weiner(Director)in
Co-investorsNew Enterprise Associates (NEA)
Solu provides a cloud-based genomic surveillance platform that analyzes microbial genomes in real-time without requiring coding or configuration.
BiotechCloud ComputingHealthtech
Sam Sihvonen(Founder)in
Co-investorsLifeline VenturesWave Ventures
Solu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels.
BiotechHealthtech
Phil Vickers(CEO / Leadership)inMichael Boretti(Leadership)inBrandon Turunen(Leadership)inSergio Santillana(Leadership)Enda Moran(Leadership)inKelly Honohan(Leadership)in
Co-investorsAstellas Venture Management LLCLongwood Fund
Us2.ai provides FDA-cleared AI software that automatically analyzes echocardiograms and generates structured clinical reports in real time.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Co-investorsEast Post Road VenturesPartech VenturesPeak XV Partners
VFlowTech develops PowerCube vanadium flow battery energy storage systems for commercial, industrial, grid and distributed generation applications in the renewable energy market.
CleantechClimate TechEnergyHardwareSingapore, SG
Avishek Kumar(CEO)inArjun Bhattarai(CTO)in
Co-investorsEntrepreneur FirstUntroD CapitalAntares Ventures Pte. Ltd.Granite AsiaMOL PLUSSEEDS Capital+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
1 IPOsAktis OncologyNASDAQ: AKTS
Portfolio news
latest coverage across their companiesVFlowTech · reuters.com · May 14, 2025
Solu · axios.com · Apr 10, 2025
Public market activity · per SEC filings
what is this? ⓘDisclosed stake · filed Feb 2016
Disclosed stake · filed Feb 2016
Disclosed stake · filed Feb 2016
Disclosed stake · filed Feb 2015
Disclosed stake · filed Mar 2014
Disclosed stake · filed Feb 2014
Disclosed stake · filed Nov 2012
Disclosed stake · filed Jul 2011
Disclosed stake · filed May 2011
Disclosed stake · filed Aug 2010
Disclosed stake · filed Mar 2006
Disclosed stake · filed Dec 2005
14 insider ownership filings (Forms 3/4/5)
From the firm's own SEC EDGAR filings — stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.
Frequently asked questions
- How many investments has Pappas Capital made?
- Pappas Capital has 12 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Pappas Capital invest at?
- Pappas Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What is Pappas Capital's typical check size?
- Pappas Capital typically writes checks of $100K – $6M.
- What sectors does Pappas Capital focus on?
- Pappas Capital focuses on Biotech, Healthtech, Medical Devices.
- Where is Pappas Capital located?
- Pappas Capital is headquartered in Research Triangle Park, US.
Images
Co-investors · 6
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Avoro Capital Advisors is an investment firm focused on healthcare and life sciences, pursuing scientific breakthroughs that address unmet medical needs.
Amplitude Venture Capital is a Canadian venture firm that creates, builds, and grows precision medicine companies aimed at improving patient outcomes.
Firms observed investing alongside Pappas Capital, from public investor directories. Shared companies are the overlap with Pappas Capital's recorded portfolio.
Similar investors
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.









































.webp)




















.jpeg)
